Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by wagyusteakon Nov 13, 2020 10:21am

96 Views

Post# 31894597

RE:RE:Does anyone sell today?? Let me buy your shares @ $1-$3

Benedict16th wrote: The market is so inpressed of this MNGT team Q3 report. The share price shot up by hge 5 cents. OMG ...The exit door is getting closer and closer for mngt. Ne new deal, not guidence and 400 millions idle. If six years ago you blind folded a monkey with darts shooting on a board to selcts investments to buy for a billion dollars worth the monkey would have done a hell of a lot better with a 10% yearly return

Lolll. this dude is so desparate. he counts every single cents.. lolll

Bullboard Posts

Sirios Resource discovers visible gold in Quebec